221 related articles for article (PubMed ID: 30557615)
1. Engineering two species of yeast as cell factories for 2'-fucosyllactose.
Hollands K; Baron CM; Gibson KJ; Kelly KJ; Krasley EA; Laffend LA; Lauchli RM; Maggio-Hall LA; Nelson MJ; Prasad JC; Ren Y; Rice BA; Rice GH; Rothman SC
Metab Eng; 2019 Mar; 52():232-242. PubMed ID: 30557615
[TBL] [Abstract][Full Text] [Related]
2. Production of a human milk oligosaccharide 2'-fucosyllactose by metabolically engineered Saccharomyces cerevisiae.
Yu S; Liu JJ; Yun EJ; Kwak S; Kim KH; Jin YS
Microb Cell Fact; 2018 Jun; 17(1):101. PubMed ID: 29950173
[TBL] [Abstract][Full Text] [Related]
3. Human milk oligosaccharide 2'-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers.
Berger PK; Plows JF; Jones RB; Alderete TL; Yonemitsu C; Poulsen M; Ryoo JH; Peterson BS; Bode L; Goran MI
PLoS One; 2020; 15(2):e0228323. PubMed ID: 32049968
[TBL] [Abstract][Full Text] [Related]
4. Biosynthesis of a Functional Human Milk Oligosaccharide, 2'-Fucosyllactose, and l-Fucose Using Engineered Saccharomyces cerevisiae.
Liu JJ; Kwak S; Pathanibul P; Lee JW; Yu S; Yun EJ; Lim H; Kim KH; Jin YS
ACS Synth Biol; 2018 Nov; 7(11):2529-2536. PubMed ID: 30350568
[TBL] [Abstract][Full Text] [Related]
5. High-Titer
Parschat K; Schreiber S; Wartenberg D; Engels B; Jennewein S
ACS Synth Biol; 2020 Oct; 9(10):2784-2796. PubMed ID: 32966739
[TBL] [Abstract][Full Text] [Related]
6. Pre-clinical safety evaluation of the synthetic human milk, nature-identical, oligosaccharide 2'-O-Fucosyllactose (2'FL).
Coulet M; Phothirath P; Allais L; Schilter B
Regul Toxicol Pharmacol; 2014 Feb; 68(1):59-69. PubMed ID: 24262411
[TBL] [Abstract][Full Text] [Related]
7. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine.
Good M; Sodhi CP; Yamaguchi Y; Jia H; Lu P; Fulton WB; Martin LY; Prindle T; Nino DF; Zhou Q; Ma C; Ozolek JA; Buck RH; Goehring KC; Hackam DJ
Br J Nutr; 2016 Oct; 116(7):1175-1187. PubMed ID: 27609061
[TBL] [Abstract][Full Text] [Related]
8. Biochemical characterization of a novel α-L-fucosidase from Pedobacter sp. and its application in synthesis of 3'-fucosyllactose and 2'-fucosyllactose.
Shi R; Ma J; Yan Q; Yang S; Fan Z; Jiang Z
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5813-5826. PubMed ID: 32388762
[TBL] [Abstract][Full Text] [Related]
9. Improved production of 2'-fucosyllactose in engineered Saccharomyces cerevisiae expressing a putative α-1, 2-fucosyltransferase from Bacillus cereus.
Xu M; Meng X; Zhang W; Shen Y; Liu W
Microb Cell Fact; 2021 Aug; 20(1):165. PubMed ID: 34425826
[TBL] [Abstract][Full Text] [Related]
10. Engineering the Substrate Transport and Cofactor Regeneration Systems for Enhancing 2'-Fucosyllactose Synthesis in
Deng J; Gu L; Chen T; Huang H; Yin X; Lv X; Liu Y; Li N; Liu Z; Li J; Du G; Liu L
ACS Synth Biol; 2019 Oct; 8(10):2418-2427. PubMed ID: 31550146
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal change of selected human milk oligosaccharides and association to infants' growth, an observatory, single center, longitudinal cohort study.
Sprenger N; Lee LY; De Castro CA; Steenhout P; Thakkar SK
PLoS One; 2017; 12(2):e0171814. PubMed ID: 28182762
[TBL] [Abstract][Full Text] [Related]
12. Metabolic engineering of Escherichia coli to produce 2'-fucosyllactose via salvage pathway of guanosine 5'-diphosphate (GDP)-l-fucose.
Chin YW; Seo N; Kim JH; Seo JH
Biotechnol Bioeng; 2016 Nov; 113(11):2443-52. PubMed ID: 27217241
[TBL] [Abstract][Full Text] [Related]
13. Infants Fed a Lower Calorie Formula With 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants.
Marriage BJ; Buck RH; Goehring KC; Oliver JS; Williams JA
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):649-58. PubMed ID: 26154029
[TBL] [Abstract][Full Text] [Related]
14. The oligosaccharides 6'-sialyllactose, 2'-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation.
Perdijk O; van Neerven RJJ; van den Brink E; Savelkoul HFJ; Brugman S
PLoS One; 2018; 13(7):e0200356. PubMed ID: 29990329
[TBL] [Abstract][Full Text] [Related]
15. Human Milk Oligosaccharide 2'-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model.
Xiao L; Leusink-Muis T; Kettelarij N; van Ark I; Blijenberg B; Hesen NA; Stahl B; Overbeek SA; Garssen J; Folkerts G; Van't Land B
Front Immunol; 2018; 9():452. PubMed ID: 29593719
[TBL] [Abstract][Full Text] [Related]
16. Strategies for Enhancing Microbial Production of 2'-Fucosyllactose, the Most Abundant Human Milk Oligosaccharide.
Liu Y; Zhu Y; Wang H; Wan L; Zhang W; Mu W
J Agric Food Chem; 2022 Sep; 70(37):11481-11499. PubMed ID: 36094047
[TBL] [Abstract][Full Text] [Related]
17. Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2'-fucosyllactose.
Baumgärtner F; Seitz L; Sprenger GA; Albermann C
Microb Cell Fact; 2013 May; 12():40. PubMed ID: 23635327
[TBL] [Abstract][Full Text] [Related]
18. Identification and Characterization of a Novel α-L-Fucosidase from
Zhang Z; Li Y; Wu M; Gao Z; Wu B; He B
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511315
[TBL] [Abstract][Full Text] [Related]
19. Effects of
Mao B; He Z; Chen Y; Stanton C; Ross RP; Zhao J; Chen W; Yang B
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558551
[TBL] [Abstract][Full Text] [Related]
20. Sialylated galacto-oligosaccharides and 2'-fucosyllactose reduce necrotising enterocolitis in neonatal rats.
Autran CA; Schoterman MH; Jantscher-Krenn E; Kamerling JP; Bode L
Br J Nutr; 2016 Jul; 116(2):294-9. PubMed ID: 27212112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
